therapeutic progesterone

Phase 1Biologic

EEmory University

therapeutic progesterone is one of 64 biologic programs targeting Breast Cancer. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast CancerActive, not recruiting

GlioblastomaActive, not recruiting

Breast CancerPreclinical

Active, not recruiting

GlioblastomaPhase 1

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Tecentriq

Roche

Preclinical

36 2

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Preclinical

78 3

Avastin

DATROWAY

4 5

Blenoxane

Bristol-Myers Squibb

Preclinical

1 6

Voltaren

Novartis

Preclinical

1 7

Lupron

EEastern Cooperative Oncology Group

Preclinical

5 8

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 9

Tricor

JJagotec

Preclinical

1 10

Apatinib Mesylate

BBukwang Pharmaceutical

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 1Active, not recruiting

Glioblastoma

NCT05091866

Clinical

Trials by Indication[1]

Breast Cancer1 trial

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Unknown status·IInstitute of Cancer Research, United Kingdom·N/A·NCT00079248

Glioblastoma1 trial

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Active, not recruiting·EEmory University·Phase 1·NCT05091866·4 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for therapeutic progesterone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — therapeutic progesterone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for therapeutic progesterone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Emory University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 1[1]
Company: EEmory University

therapeutic progesterone

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Breast Cancer1 trial

Glioblastoma1 trial

References

Drug Info

Quick Facts

Related News